Latest Breaking News On - பிராண்ட் நிறுவனம் - Page 6 : comparemela.com

Miami-based naming agency is the global leader in pharmaceutical name development MIAMI, Dec. 28, 2020 /PRNewswire/  Brand Institute, the global leader in pharmaceutical and healthcare related name development, is proud to announce its role in naming Pfizer and BioNTech’s COVID-19 vaccine: COMIRNATY® (koe mir’ na tee). The name was first announced by Swiss regulatory authority, Swissmedic. Shortly after, it was included in the conditional marketing authorization published by the European Medicines Agency (EMA). The approval of the brand name by other global regulatory agencies will follow their respective guidelines, policies and procedures. In a joint press release, BioNTech and Pfizer commented on the vaccine’s brand name, “The vaccine will be marketed in the EU under the brand name COMIRNATY®, which represents a combination of the terms COVID-19, mRNA, community and immunity, to highlight the first authorization of a messenger RNA (mRNA) vaccine, as well as the joint

United statesScott piergrossipresidentJamesl dettoreDrug safety instituteBrand instituteWorld health organizationAmerican medical associationOperations communicationsEuropean medicines agencyHealth canadaDrug safetySafety instituteஒன்றுபட்டது மாநிலங்களில்மருந்து பாதுகாப்பு நிறுவனம்பிராண்ட் நிறுவனம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்